Shenduo Li
Hematology & Oncology · Jacksonville, FLNPI 1134509771
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,862 of the $2,394 with a category attached, or 77.8%. It is spread thinly across 17 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $962 and has fallen 73.0% since, to $260 in 2025. That places this record below the midpoint for hematology & oncology clinicians in FL, where the typical reported total is $3,884.
Across 31 payments — averaging $77.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$518
- Amgen$441
- AstraZeneca$200
- Johnson & Johnson$161
- Pfizer$136
- Puma Biotechnology, Inc.$123
- plus $815 from 11 others
What the payments were for
- Food & beverage$1,86278%
- Education$53222%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 7 | $518 |
| Amgen | 5 | $441 |
| AstraZeneca | 2 | $200 |
| Johnson & Johnson(2 entities) | 3 | $161 |
| Pfizer | 2 | $136 |
| Puma Biotechnology, Inc. | 1 | $123 |
| Sanofi | 1 | $122 |
| Nevro Corp. | 1 | $103 |
| Rigel Pharmaceuticals, Inc. | 1 | $103 |
| Exelixis Inc. | 1 | $85 |
| Merck | 1 | $85 |
| G1 Therapeutics, Inc. | 1 | $84 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| ADC Therapeutics America, Inc. | 1 | $68 |
| Regeneron Healthcare Solutions, Inc. | 1 | $60 |
| Astellas Pharma US Inc | 1 | $19 |
| Omeros Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,394 in reported general payments places this provider in the 40th percentile of 694 hematology & oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 12 | $258 |
| Prochlorperazine Maleate | 11 | $82 |
| Dexamethasone | 17 | $56 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Jacksonville
- Edith PerezJacksonville$1.1M
- Vamsidhar VelchetiJacksonville$966K
- Arnab BasuJacksonville$440K
- Sikander AilawadhiJacksonville$179K
- James ForanJacksonville$164K
- Asher Chanan KhanJacksonville$109K
- Martin DietrichRockledge$6.2M
- Mark SocinskiOrlando$2.4M
- Tarek MekhailOrlando$2.2M
- Edgardo SantosFort Lauderdale$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.